Equity Research, Broker Reports, and media content on Hemogenyx Pharmaceuticals

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Hemogenyx Pharmaceuticals
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Hemogenyx Pharmaceuticals. We currently have 21 research reports from 3 professional analysts.

Open
2.38p
Range Today
2.36/2.38p
52 Week
1.68/3.40p
Daily Volume
100.2k
# Shares
364.7m
Daily Liquidity
(0.03%)
Pension Liability
£0m
Enterprise Value
£7.60m
Market Cap
£8.68m
Latest PE (hist)
Div Yield
Date Source Announcement
15Jan20 12:30 RNS HEMO's CAR-T Cells Effective Against AML in vitro
18Nov19 07:00 RNS Operational Update
12Nov19 07:00 RNS Presentation at the Investival Showcase
06Nov19 07:00 RNS-R Presentation at the NY Oncology Investor Conf.
23Oct19 07:00 RNS Research Agreement with Global Pharma Company
21Oct19 07:00 RNS-R Presentation at NY Stem Cell Foundation conference
30Sep19 07:00 RNS Half-year Report
  • Frequency of research reports

     

  • Research reports on

    Hemogenyx Pharmaceuticals

  • Providers covering

    Hemogenyx Pharmaceuticals